Clinical Outcomes and Non‐Invasive Testing in Metabolic Dysfunction‐Associated Steatohepatitis With Cirrhosis: A Systematic Review
This SLR identified data on a range of clinical outcomes in patients with MASH-related cirrhosis. However, there was limited evidence for certain outcomes including the role of prognostic prediction models for liver-related events in this patient population.
Authors
- Chris Hellmund
- Riku Ota (ORCID: https://orcid.org/0000-0002-6379-4376)
- Hannes Hagström
- Jeffrey V. Lazarus
- Giada Sebastiani
- Mazen Noureddin
- Mary E. Rinella
- Zobair M. Younossi
- Fotis Tefos
Institutions
- Oxford Instruments (United Kingdom) (GB)
- Inova Health System (US)
- The Graduate Center, CUNY (US)
- Karolinska University Hospital (SE)
- Novo Nordisk (Denmark) (DK)
- McGill University Health Centre (CA)
- Karolinska Institutet (SE)
- University of Chicago (US)
- Methodist Hospital (US)
- Houston Institute for Clinical Research (US)
- Barcelona Institute for Global Health (ES)
Publication Details
- Journal
- Liver International
- Published
- 2026-03-28
- DOI
- https://doi.org/10.1111/liv.70608
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00